Cargill Makes Multimillion Investment in French Alginates Plant - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Cargill Makes Multimillion Investment in French Alginates Plant

Cargill is investing $15 million to upgrade and expand its alginates production plant in Lannilis, Brittany, France. The investment will fund several upgrades to the plant, including capacity expansion, safety upgraded, and improved wastewater processing. The production plant is located in close proximity to the French coast, where Cargill works with local fisherman to secure a source of fresh brown seaweed, from which the alginate is extracted.

Cargill offers a variety of alginates with gelling and thickening functionalities for applications in pharmaceuticals, food and beverages.

Source: Cargill


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here